These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 18814369)

  • 21. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.
    Hicks CB
    AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369
    [No Abstract]   [Full Text] [Related]  

  • 22. New insights into HIV resistance testing: nursing guidelines and implications.
    Kirton CA; Kurtyka D; Sterken DJ
    J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance and replication capacity assays: clinical utility and interpretation.
    Haubrich RH
    Top HIV Med; 2004; 12(2):52-6. PubMed ID: 15184711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV resistance testing. A clinical tool.
    Paul SM; Jorden VS
    N J Med; 2003 Sep; 100(9 Suppl):44-9; quiz 75-6. PubMed ID: 14556603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolving role of antiretroviral drug resistance testing in HIV-infected individuals.
    Idemyor V
    HIV Clin Trials; 2002; 3(5):413-7. PubMed ID: 12407491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using HIV resistance tests in clinical practice.
    Taylor S; Jayasuriya A; Smit E
    J Antimicrob Chemother; 2009 Aug; 64(2):218-22. PubMed ID: 19535382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding transmitted HIV resistance through the experience in the USA.
    Taiwo B
    Int J Infect Dis; 2009 Sep; 13(5):552-9. PubMed ID: 19136289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-resistant human immunodefiency virus.
    Kozal MJ
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():69-73. PubMed ID: 19220361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update of the Drug Resistance Mutations in HIV-1.
    Johnson VA; Brun-Vezinet F; Clotet B; Gunthard HF; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD
    Top HIV Med; 2008 Dec; 16(5):138-45. PubMed ID: 19106428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Consensus documents and clinical guidelines on resistance to antiretroviral agents].
    Antela A; Iribarren JA; Clotet B; Guerra L
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):47-52. PubMed ID: 11428061
    [No Abstract]   [Full Text] [Related]  

  • 31. [Selection and use of tests for detecting HIV resistance].
    Eiros JM; Hernández B; Labayru C; de Lejarazu RO
    Rev Esp Quimioter; 2001 Sep; 14(3):242-53. PubMed ID: 11753445
    [No Abstract]   [Full Text] [Related]  

  • 32. [GESIDA Consensus document on the use of resistance studies in clinical practice].
    Gatell JM; Blanco JL; Alcamí J; Antela A; Arrizabalaga J; Casado JL; Clotet B; Delgado R; Erice A; Guerra L; Guerrero A; Iribarren JA; Leal M; López JC; Menéndez-Arias L; Miró JM; Moreno S; Pérez JL; Pumarola T; Rubio R; Ruiz L; Santamaría JM; Soriano V; Telenti A; Viciana P
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):53-60. PubMed ID: 11428062
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs for HIV infection.
    Treat Guidel Med Lett; 2011 Jun; 9(106):29-40. PubMed ID: 21617596
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primary resistance to antiretroviral agents].
    Soriano V; María Miró J; Guerrero A
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):22-5. PubMed ID: 11428054
    [No Abstract]   [Full Text] [Related]  

  • 36. The K65R mutation: selection, frequency, and possible consequences.
    Moyle GJ
    AIDS Read; 2004 Nov; 14(11):595-7, 601-3. PubMed ID: 15570671
    [No Abstract]   [Full Text] [Related]  

  • 37. New developments in HIV drug resistance.
    Cane PA
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinically validated genotype analysis: guiding principles and statistical concerns.
    Brun-Vézinet F; Costagliola D; Khaled MA; Calvez V; Clavel F; Clotet B; Haubrich R; Kempf D; King M; Kuritzkes D; Lanier R; Miller M; Miller V; Phillips A; Pillay D; Schapiro J; Scott J; Shafer R; Zazzi M; Zolopa A; DeGruttola V
    Antivir Ther; 2004 Aug; 9(4):465-78. PubMed ID: 15456077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug resistance in HIV infection].
    Asjö B; Langeland N
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2593-6. PubMed ID: 19023373
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.